NTL Healthcare is exhibited CerviCARE at KIMES 2022 – Korea International Medical & Hospital Equipment Show.
#Exhibition #Tokyo Big Sight #Makuhari Messe #Pacifico Yokohama
Hello, we are NTL Healthcare.
We are developing and supplying a remote cervical cancer screening system.
We are a company that develops a cervix diagnostic imaging device and a platform that can remotely request an imaged cervix to a specialist.
We are developing and supplying a remote cervical cancer screening system.
We are a company that develops a cervix diagnostic imaging device and a platform that can remotely request an imaged cervix to a specialist.
Currently, we have been providing this service in Korea for 25 years,
and about 500,000 people are diagnosed with cervical cancer every year through this screening system.
and about 500,000 people are diagnosed with cervical cancer every year through this screening system.
Recently, by applying an AI artificial intelligence solution,
we added a function to analyze the captured video in real-time.
There may be several competitors, but we are different in that we have already been verified in Korea.
There may be several competitors, but we are different in that we have already been verified in Korea.
Since 1996 in Korea, obstetrics and gynecology have been supplying this system steadily,
and the current domestic obstetrics and gynecology market share is about 70%,
and the current domestic obstetrics and gynecology market share is about 70%,
and about 500,000 people are being screened every year.
If you would like to purchase or collaborate, please contact us on our ntlhealthcare.com web page,
and we will help you by videoconference or contact.
We are a company that is very specialized in developing cervical cancer diagnostic equipment and platforms.
Cervical cancer is a disease that the mothers and sisters of the family around me are likely to get,
so I am dedicated to it more than anyone else.
